Posted by
Seth Gordon , Dr. Richard Stefanacci on 4 月 29, 20204/29/20
The application of clinical pathways and their enforcement through quality metric benchmark setting and appropriate use criteria is needed to guard against perverse financial incentives that encourage overutilization and underutilization. Moving forward, the more diligent payers…